코엔자임 Q10 시장 규모 : 용도별, 조사 보고서, 국가별 전망, 가격 동향, 성장 전망, 경쟁사 점유율, 세계 예측(2024-2032년)

Coenzyme Q10 Market size is projected to expand at over 10.7% CAGR from 2024 to 2032, led by the rapid growth of the cosmetics and personal care sector. Coenzyme Q10 is widely incorporated into various skincare and beauty products for its antioxidant properties for reducing signs of aging and improving skin health. Formulators are enhancing the stability and absorption of Coenzyme Q10 in topical applications to maximize its benefits.

Moreover, advancements in formulation technologies are driving further integration into a broader range of personal care products for more effective solutions for skin rejuvenation and protection. For instance, in April 2024, Beiersdorf launched the Nivea Q10 Dual Action Serum featuring Coenzyme Q10 paired with a glycation inhibitor for enhancing skin health by providing powerful anti-aging and protective benefits.

The overall market is segregated into application and region.

Based on application, the coenzyme Q10 market value from the pharmaceuticals segment is expected to rise at significant rate from 2024 to 2032. The growth is on account of rising adoption in diverse pharmaceuticals applications, such as improving cardiovascular health, managing mitochondrial disorders and supporting overall energy levels. Researchers are optimizing the delivery and absorption of coenzyme Q10 to maximize its therapeutic benefits. Growing prominence in modern medicine and health management will also influence the segment growth.

Regionally, the Europe coenzyme Q10 market size is projected to witness robust growth between 2024 and 2032, due to rising incorporation into sports nutrition and the expansion of the nutraceutical sector. Coenzyme Q10 is largely added to sports supplements to enhance energy, endurance, and recovery for athletes.

Simultaneously, the nutraceutical sector is integrating this ingredient into various products to support the overall health and wellness. Researchers and formulators in the region are also improving the bioavailability and efficacy of Coenzyme Q10 in various applications to drive innovations. The ongoing developments to enhance formulations and new opportunities for Coenzyme Q10 for supporting active lifestyles and holistic health approaches will add to the regional product demand.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Key manufacturers
  • 3.1.2 Distributors
  • 3.1.3 Profit margins across the industry
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Market challenges
  • 3.2.3 Market opportunity
    • 3.2.3.1 New opportunities
    • 3.2.3.2 Growth potential analysis
• 3.3 Raw material landscape
  • 3.3.1 Manufacturing trends
  • 3.3.2 Technology evolution
    • 3.3.2.1 Sustainable manufacturing
      • 3.3.2.1.1 Green practices
      • 3.3.2.1.2 Decarbonization
  • 3.3.3 Sustainability in raw materials
  • 3.3.4 Pricing trends (USD/Ton)
    • 3.3.4.1 North America
    • 3.3.4.2 Europe
    • 3.3.4.3 Asia Pacific
    • 3.3.4.4 Latin America
    • 3.3.4.5 Middle East & Africa
• 3.4 Regulations & market impact
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Application, 2021-2032 (USD Billion, Kilo Tons)

• 5.1 Key trends
• 5.2 Dietary supplements
• 5.3 Pharmaceuticals
• 5.4 Cosmetics
• 5.5 Others

Chapter 6 Market Size and Forecast, By Region, 2021-2032 (USD Billion, Kilo Tons)

• 6.1 Key trends
• 6.2 North America
  • 6.2.1 U.S.
  • 6.2.2 Canada
• 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 UK
  • 6.3.3 France
  • 6.3.4 Italy
  • 6.3.5 Spain
  • 6.3.6 Rest of Europe
• 6.4 Asia Pacific
  • 6.4.1 China
  • 6.4.2 India
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 Australia
  • 6.4.6 Rest of Asia Pacific
• 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Mexico
  • 6.5.3 Argentina
  • 6.5.4 Rest of Latin America
• 6.6 MEA
  • 6.6.1 Saudi Arabia
  • 6.6.2 UAE
  • 6.6.3 South Africa
  • 6.6.4 Rest of MEA

Chapter 7 Company Profiles

• 7.1 Kaneka Corporation
• 7.2 DSM
• 7.3 SourceOne Global Partners, LLC
• 7.4 Healthy Origins
• 7.5 Vitamin Shoppe, Inc.
• 7.6 NBTY, Inc.
• 7.7 Pharmavite LLC
• 7.8 QUTEN Research Institute LLC
• 7.9 Tishcon Corp.
• 7.10 Country Life, LLC
• 7.11 Natural Organics
• 7.12 Jarrow Formulas
• 7.13 NOW Foods
• 7.14 Pharma Nord, Inc.
• 7.15 Doctor's Best
• 7.16 Xiamen Kingdomway Group
• 7.17 GNC Holdings, Inc
• 7.18 Nordic Naturals, Inc.